Therefore, it could be used to treat chronic or degenerative diseases and to determine non-toxic and selective inhibitors of NADPH oxidases, delivering innovative drugs for treating diseases caused by oxidative stress. The gene discussed is FMO5; the disease is neurodegenerative disease.